Logo CICANCER
Intranet Colaborate

Old CIC Events

Collective downregulation of a group of tumor suppressors in response to EGF: The role of TSHZ2 in cancer progression 21/04/2022

Collective downregulation of a group of tumor suppressors in response to EGF: The role of TSHZ2 in cancer progression

Mary Luz Uribe Ríos — Centro de Investigación del Cáncer (CIC-IBMCC)

exhibición de los posters de los estudiantes de Máster 20/04/2022

exhibición de los posters de los estudiantes de Máster

Estudiantes máster de biología y clínica del cáncer — CIC

The amoeboid state as part of the epithelial-to-mesenchymal transition programme 07/04/2022

The amoeboid state as part of the epithelial-to-mesenchymal transition programme

Prof. Victoria Sanz-Moreno — Barts Cancer Institute Queen Mary University of London [London, UK]

Characterization of NOMO1 loss in early-onset colorectal cancer 24/03/2022

Characterization of NOMO1 loss in early-onset colorectal cancer

Abel J. Martel Martel — Centro de Investigación del Cáncer-Hospital Universitario de Salamanca

Stromal cytokine signalling promotes breast cancer progression by reprograming the tumor microenvironment 17/03/2022

Stromal cytokine signalling promotes breast cancer progression by reprograming the tumor microenvironment

María Muñoz Caffarel — del Instituto de Investigación Sanitaria Biodonostia/ Hospital Donostia de San Sebastián

Insights into ALK biology to unravel novel therapeutic pathways 10/03/2022

Insights into ALK biology to unravel novel therapeutic pathways

Claudia Voena — Center for Experimental Research and Medical Studies (CeRMS) University of Torino

Molecular mechanisms of DNA crosslink recognition and repair 03/03/2022

Molecular mechanisms of DNA crosslink recognition and repair

Pablo Alcón — Medical Research Council Laboratory of Molecular Biology (MRC-LMB), Cambridge (United Kingdom).

Transient JAK/STAT pathway inhibition prevents B-ALL development in genetically predisposed mice 24/02/2022

Transient JAK/STAT pathway inhibition prevents B-ALL development in genetically predisposed mice

Ana Casado García — Centro de Investigación del Cáncer (CIC-IBMCC), Salamanca

Novel therapeutic strategies against cancer metastasis: From Research to Innovation 18/02/2022

Novel therapeutic strategies against cancer metastasis: From Research to Innovation

Angélica Figueroa — Instituto de Investigación Biomédica A Coruña (INIBIC)

Epigenetic control of tissue plasticity in pancreatic regeneration and tumorigenesis. 03/02/2022

Epigenetic control of tissue plasticity in pancreatic regeneration and tumorigenesis.

Direna Alonso Curbelo — IRB, Barcelona

Understanding early lymphoma formation from a single-cell epigenomics and 3D chromatin perspective 27/01/2022

Understanding early lymphoma formation from a single-cell epigenomics and 3D chromatin perspective

Renée Beekman — Center for Genomic Regulation (CRG)

USAL Program Medical Immunology 2022 (1st Edition) 25/01/2022

USAL Program Medical Immunology 2022 (1st Edition)

Prof. Jacques J.M van Dongen — Centro de Investigación del Cáncer-Instituto de Biología Celular y Molecular del Cáncer y Leiden University Medical Center.